Fri, Dec 19, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Alexander Ineichen’s Regulomics research shows little to cheer alternative investors

Friday, June 24, 2011

By Beverly Chandler, Opalesque London:

A recent piece of research from Alexander Ineichen’s eponymous Ineichen Research & Management research boutique claims that we are in a phase of Regulomics. This he defines as the opposite to Reaganomics, which, he claims, was better for investors. While Reaganomics, which stood for lower taxes, less regulation, less government spending and controlled money supply, suited investors, Ineichen’s Regulomics, the spiritual opposite, is what investors have to deal with today.

Regulomics essentially means more government spending, higher taxes, uncontrolled money supply, and more regulation. Ineichen says: "We don’t know how this will end. However, we do know this. When big government intervenes and the market cannot function properly, small inefficiencies typically turn into big problems."

Examples of 'small inefficiences’ that turn into big problems for Ineichen, include the Euro and Ucits products. "The UCITS phenomena, covered in our April 2010 report, is another intervention. It is albeit an intervention that is welcomed by parts of the market. After the experience of 2008 many investors were not asking about the return on their investments but about the return of their investments. UCITS caters to this demand. A regulated product gives certain investors a sense of security. It is also better from a career risk perspective. Losing mon......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und